D-0545-2024 Class II
FDA drug recall D-0545-2024 was initiated by Winder Laboratories, LLC on May 28, 2024 and is designated Class II. Reason for recall: Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg. Affected quantity: 473 cases (5676 Bottles).
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2024
- Initiation Date
- May 28, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 473 cases (5676 Bottles)
Product description
Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,
Reason for recall
Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Distribution pattern
Nationwide within the United States
Code information
Lot#: 1142404 Exp. Date 02/27/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0545-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026